127 related articles for article (PubMed ID: 25277815)
21. Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E.
Rosen O; Feldberg L; Yamin TS; Dor E; Barnea A; Weissberg A; Zichel R
Sci Rep; 2017 Nov; 7(1):14859. PubMed ID: 29093524
[TBL] [Abstract][Full Text] [Related]
22. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples.
Kalb SR; Moura H; Boyer AE; McWilliams LG; Pirkle JL; Barr JR
Anal Biochem; 2006 Apr; 351(1):84-92. PubMed ID: 16500606
[TBL] [Abstract][Full Text] [Related]
23. Nanopore sensing of botulinum toxin type B by discriminating an enzymatically cleaved Peptide from a synaptic protein synaptobrevin 2 derivative.
Wang Y; Montana V; Grubišić V; Stout RF; Parpura V; Gu LQ
ACS Appl Mater Interfaces; 2015 Jan; 7(1):184-92. PubMed ID: 25511125
[TBL] [Abstract][Full Text] [Related]
24. Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay.
Kalb SR; Baudys J; Kiernan K; Wang D; Becher F; Barr JR
J Anal Toxicol; 2020 Mar; 44(2):173-179. PubMed ID: 31287544
[TBL] [Abstract][Full Text] [Related]
25. A label-free biosensor assay for botulinum neurotoxin B in food and human serum.
Ferracci G; Marconi S; Mazuet C; Jover E; Blanchard MP; Seagar M; Popoff M; Lévêque C
Anal Biochem; 2011 Mar; 410(2):281-8. PubMed ID: 21134347
[TBL] [Abstract][Full Text] [Related]
26. Modification and validation of the Endopep-mass spectrometry method for botulinum neurotoxin detection in liver samples with application to samples collected during animal botulism outbreaks.
Tevell Åberg A; Karlsson I; Hedeland M
Anal Bioanal Chem; 2021 Jan; 413(2):345-354. PubMed ID: 33119784
[TBL] [Abstract][Full Text] [Related]
27. Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro.
Ekong TAN; Feavers IM; Sesardic D
Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3337-3347. PubMed ID: 9353935
[TBL] [Abstract][Full Text] [Related]
28. Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity.
Rowe B; Schmidt JJ; Smith LA; Ahmed SA
Anal Biochem; 2010 Jan; 396(2):188-93. PubMed ID: 19782037
[TBL] [Abstract][Full Text] [Related]
29. Subtyping botulinum neurotoxins by sequential multiple endoproteases in-gel digestion coupled with mass spectrometry.
Wang D; Baudys J; Rees J; Marshall KM; Kalb SR; Parks BA; Nowaczyk L; Pirkle JL; Barr JR
Anal Chem; 2012 Jun; 84(11):4652-8. PubMed ID: 22577857
[TBL] [Abstract][Full Text] [Related]
30. An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin.
Evans ER; Skipper PJ; Shone CC
J Appl Microbiol; 2009 Oct; 107(4):1384-91. PubMed ID: 19426271
[TBL] [Abstract][Full Text] [Related]
31. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
[TBL] [Abstract][Full Text] [Related]
32. Ultrafiltration improves ELISA and Endopep MS analysis of botulinum neurotoxin type A in drinking water.
Raphael BH; Lautenschlager M; Kahler A; Pai S; Parks BA; Kalb SR; Maslanka SE; Shah S; Magnuson M; Hill VR
J Microbiol Methods; 2012 Sep; 90(3):267-72. PubMed ID: 22677607
[TBL] [Abstract][Full Text] [Related]
33. The osmolyte trimethylamine N-oxide (TMAO) increases the proteolytic activity of botulinum neurotoxin light chains A, B, and E: implications for enhancing analytical assay sensitivity.
Nuss JE; Wanner LM; Tressler LE; Bavari S
J Biomol Screen; 2010 Sep; 15(8):928-36. PubMed ID: 20720092
[TBL] [Abstract][Full Text] [Related]
34. Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera.
Babrak L; Lin A; Stanker LH; McGarvey J; Hnasko R
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26742073
[TBL] [Abstract][Full Text] [Related]
35. Peptide inhibitors of botulinum neurotoxin by mRNA display.
Yiadom KP; Muhie S; Yang DC
Biochem Biophys Res Commun; 2005 Oct; 335(4):1247-53. PubMed ID: 16122707
[TBL] [Abstract][Full Text] [Related]
36. Studies on botulinum neurotoxins type /C1 and mosaic/DC using Endopep-MS and proteomics.
Moura H; Terilli RR; Woolfitt AR; Gallegos-Candela M; McWilliams LG; Solano MI; Pirkle JL; Barr JR
FEMS Immunol Med Microbiol; 2011 Apr; 61(3):288-300. PubMed ID: 21205003
[TBL] [Abstract][Full Text] [Related]
37. Detection of Botulinum Toxins A, B, E, and F in Foods by Endopep-MS.
Kalb SR; Krilich JC; Dykes JK; Lúquez C; Maslanka SE; Barr JR
J Agric Food Chem; 2015 Feb; 63(4):1133-1141. PubMed ID: 25578960
[TBL] [Abstract][Full Text] [Related]
38. Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples.
Bagramyan K; Kaplan BE; Cheng LW; Strotmeier J; Rummel A; Kalkum M
Anal Chem; 2013 Jun; 85(11):5569-76. PubMed ID: 23656526
[TBL] [Abstract][Full Text] [Related]
39. Validation of the Endopep-MS method for qualitative detection of active botulinum neurotoxins in human and chicken serum.
Björnstad K; Tevell Åberg A; Kalb SR; Wang D; Barr JR; Bondesson U; Hedeland M
Anal Bioanal Chem; 2014 Nov; 406(28):7149-61. PubMed ID: 25228079
[TBL] [Abstract][Full Text] [Related]
40. Buforin I, a natural peptide, inhibits botulinum neurotoxin B activity in vitro.
Garcia GE; Moorad DR; Gordon RK
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S19-22. PubMed ID: 10594894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
